Table 2.
Patient characteristics
n | % | |
---|---|---|
All patients | 266 | 100.00 |
Male | 179 | 67.30 |
Female | 87 | 32.70 |
First diagnosis | ||
Mean age (SD) in years | 63.0 (+/− 9.7) | |
Primary tumor | ||
located in Colon (C18) | 151 | 56.77 |
Rectosigmoid junction (C19) | 18 | 6.77 |
Rectum (C20) | 98 | 36.84 |
T1,T2 | 29 | 10.90 |
T3,T4 | 227 | 85.30 |
T missing | 10 | 3.80 |
N0 | 74 | 27.80 |
N1,2 | 179 | 67.30 |
N status missing | 13 | 4.90 |
Synchronous metastases | 166 | 62.41 |
Prior treatment | ||
Systemic chemotherapy | 248 | 93.23 |
Median lines of chemotherapy (range) | 2 (0–8) | |
Radiochemotherapy | 30 | 11.28 |
Surgery for colorectal primary | 263 | 98.87 |
Radiation therapy for colorectal primary | 21 | 7.89 |
Surgery for liver metastases | 91 | 34.21 |
Other local treatment for liver metastases | 40 | 15.04 |
Surgery for lung metastases | 14 | 5.26 |
Surgery for other metastases | 20 | 7.52 |
Local therapy for other metastases | 5 | 1.88 |
First interventional treatment | ||
Mean age (SD) in years | 66,5 (+/−9.6) | |
Age > 70 years | 89 | 33.5 |
Median Karnofsky index (range) in % | 80 (50–100) | |
Liver metastases | 251 | 96.99 |
Liver metastases only | 121 | 45.50 |
Liver involvement > 25% | 45 | 16.92 |
Lung involvement | 100 | 37.60 |
Other | 83 | 31.20 |
≥ 2 organ systems involved | 140 | 52.63 |